BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22678099)

  • 1. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
    AlSharari SD; Carroll FI; McIntosh JM; Damaj MI
    J Pharmacol Exp Ther; 2012 Sep; 342(3):742-9. PubMed ID: 22678099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
    Caldarone BJ; Wang D; Paterson NE; Manzano M; Fedolak A; Cavino K; Kwan M; Hanania T; Chellappan SK; Kozikowski AP; Olivier B; Picciotto MR; Ghavami A
    Psychopharmacology (Berl); 2011 Sep; 217(2):199-210. PubMed ID: 21487659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
    Turner JR; Castellano LM; Blendy JA
    J Pharmacol Exp Ther; 2010 Aug; 334(2):665-72. PubMed ID: 20435920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice.
    Kutlu MG; Tumolo JM; Cann C; Gould TJ
    Psychopharmacology (Berl); 2018 Apr; 235(4):1211-1219. PubMed ID: 29383396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
    Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
    Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Kamens HM; Andersen J; Picciotto MR
    Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
    Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
    Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM; Stevens KE
    Pharmacol Biochem Behav; 2011 Nov; 100(1):17-24. PubMed ID: 21763340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.
    Rollema H; Russ C; Lee TC; Hurst RS; Bertrand D
    Nicotine Tob Res; 2014 Jun; 16(6):733-42. PubMed ID: 24406270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.
    Slater CA; Jackson A; Muldoon PP; Dawson A; O'Brien M; Soll LG; Abdullah R; Carroll FI; Tapper AR; Miles MF; Banks ML; Bettinger JC; Damaj IM
    Alcohol Clin Exp Res; 2016 Jan; 40(1):62-72. PubMed ID: 26727524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.